Patent · US Active

Blood analysis method, control device and blood cell analyzer

US11327070B2 · kind B2 · utility

0Cited by
6References
10Claims
0Family size

Assignee

Inventors

Key dates

Filing dateFeb 15, 2019
Grant dateMay 10, 2022
Priority date
Expiry dateNov 15, 2039

Classification

  • Technology area (CPC G)Physics
  • CPC primaryG01N2333/805
  • WIPO fieldMeasurement
  • WIPO sectorInstruments

Abstract

The present disclosure provided a blood cell analyzer, a control device and a blood analysis method thereof. In the method, a first reagent is mixed with a sample to obtain a first testing sample, and then a second reagent is mixed with the first testing sample for a further reaction to get a second testing sample for basophil classification and/or HGB measurement. A blood sample may be tested in one reaction cell through time-division multiplexing technology to obtain four groups leukocytes classification result and HGB result by single detection channel. Thus, the structure of the analyzer may be greatly simplified on the premise of guaranteeing the performance of the analyzer, the size and cost of the analyzer may reduce and a performance-price ratio of the analyzer may increase.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.